Related Experiment Videos
Treating depression with selective serotonin reuptake inhibitors: a practical approach
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. 55905, USA.
Mayo Clinic Proceedings
|July 11, 2001
Summary
Selective serotonin reuptake inhibitors (SSRIs) offer improved safety for treating depression. This review covers practical aspects of initiating, monitoring, and discontinuing SSRIs for various depression types.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Depression is a prevalent, potentially chronic, and recurrent mood disorder.
- It significantly impacts patient well-being, self-esteem, relationships, and daily functioning.
- Selective serotonin reuptake inhibitors (SSRIs) have an improved safety profile, enabling broader depression treatment.
Purpose of the Study:
- To synthesize current knowledge on selective serotonin reuptake inhibitors (SSRIs) for depression treatment.
- To provide practical guidance on the clinical use of SSRIs.
- To discuss considerations for various depression subtypes and SSRI management.
Main Methods:
- Literature synthesis of published reviews and psychopharmacology resources.
- Focus on practical aspects of SSRI initiation, monitoring, continuation, and discontinuation.
- Inclusion of precautions and considerations for diverse depression presentations.
Main Results:
- SSRIs are increasingly used for milder depression due to their safety profile.
- Practical management strategies for SSRI therapy are essential for effective treatment.
- Understanding SSRI precautions is crucial for patient safety and optimal outcomes.
Conclusions:
- SSRIs represent a valuable therapeutic option for managing depression.
- Comprehensive guidance on SSRI use is necessary for clinicians.
- Tailoring SSRI treatment to individual patient needs and depression characteristics is key.